<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02279108</url>
  </required_header>
  <id_info>
    <org_study_id>1408153</org_study_id>
    <secondary_id>2014-004005-32</secondary_id>
    <nct_id>NCT02279108</nct_id>
  </id_info>
  <brief_title>Study Assessing The Interest of Indocyanine Green Fluorescence Imaging With Radioisotope Method For Sentinel Lymph Node Biopsy in Patients With Breast Cancer</brief_title>
  <acronym>FLUOTECH</acronym>
  <official_title>Comparative, Prospective, Randomized Study Assessing The Interest of Indocyanine Green Fluorescence Imaging With Radioisotope Method For Sentinel Lymph Node Biopsy in Patients With Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The sentinel node has a fundamental role in the management of early breast cancer.

      Currently, the double detection of blue and radioisotope is recommended. A radioactive
      material requires the presence of a nuclear medicine department and the approval of health
      authorities. In many centers, this technique is not available. The use of blue is easier to
      implement technique. However, allergic reactions and prolonged breast tattoo led many teams
      to stop the practice.

      So in common practice, many center use a single method. However, with a single detection, the
      risk of false negatives and the identification failure rate increased to a significant extent
      and the number of sentinel lymph node detected and removed is not enough.

      Under these conditions, find another method of detection seems crucial. According to the
      literature, the fluorescence method (ICG) is a technique that seems safe and reliable.

      The investigators therefore propose a prospective, randomized study to investigate the
      interest of fluorescence associated with the isotopic method.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2014</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Patients With Less Than Two Lymph Nodes Detected</measure>
    <time_frame>peroperative</time_frame>
    <description>Number of patients with less than two lymph nodes detected by indocyanine (ICG) + isotope versus isotope detection alone</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Lymph Nodes ICG Positive and Tc Positive</measure>
    <time_frame>Peroperative</time_frame>
    <description>Number of lymph nodes Indocyanine green (ICG) positive and Tc (Technetium)positive</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Lymph Nodes ICG Positive and Tc Negative</measure>
    <time_frame>Peroperative</time_frame>
    <description>Number of lymph nodes Indocyanine green (ICG) positive and Tc (Technetium) negative</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Lymph Nodes ICG Negative and Tc Positive</measure>
    <time_frame>Peroperative</time_frame>
    <description>Number of lymph nodes Indocyanine green (ICG) negative and Tc (Technetium) positive</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison Between Groups of the Time of the Surgery</measure>
    <time_frame>Peroperative</time_frame>
    <description>time from incision to wound closure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison Between Groups of Anesthesia Time</measure>
    <time_frame>Peroperative</time_frame>
    <description>time from the injection of anesthesic to the waking</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time From Injection of One Dose ICG Injection to Incision Time</measure>
    <time_frame>Peroperative</time_frame>
    <description>time from injection of one dose ICG injection to incision time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison Between Groups of Time Surgery Node</measure>
    <time_frame>Peroperative</time_frame>
    <description>time from incision time to the last node surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With ICG Allergy</measure>
    <time_frame>peroperative</time_frame>
    <description>allergy is : redness, edema, itching, larynges edema and/or allergic shock</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With ICG Allergy</measure>
    <time_frame>1 hour after the end of the surgery</time_frame>
    <description>allergy is : redness, edema, itching, larynges edema and/or allergic shock</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With ICG Allergy</measure>
    <time_frame>Month 2</time_frame>
    <description>allergy is : redness, edema, itching, larynges edema and/or allergic shock</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">99</enrollment>
  <condition>Breast Neoplasms</condition>
  <arm_group>
    <arm_group_label>double detection Indocyanine + isotope</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>intradermal injection of 2.5 milligrams of indocyanine green and 20 MBq of technetium 99 before breast surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>isotope detection alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intradermal injection of 20 MBq of technetium 99 before breast surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>indocyanine green</intervention_name>
    <description>One injection, 2.5 milligrams per patient, intradermal use</description>
    <arm_group_label>double detection Indocyanine + isotope</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>isotope</intervention_name>
    <description>One injection, 20 MBq techntium99, intradermal use</description>
    <arm_group_label>double detection Indocyanine + isotope</arm_group_label>
    <arm_group_label>isotope detection alone</arm_group_label>
    <other_name>technetium</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histologically proved infiltrating breast cancer (ductal, lobular carcinoma…) or a
             carcinoma in-situ with an elevated risk of micro-invasion. (High grade with necrosis,
             radiologically evaluated size more than 40mm, or immediate mastectomy…)

          -  Unifocal or multifocal but in same quarter

          -  Size &lt; 5cm clinically palpable or not

          -  Clinically or ultrasound axillary N0

          -  Isotopic sentinel node detection

          -  Adult patient

          -  Signed informed consent by patient or legally responsable authority

          -  Patient registered to a social security system

          -  No surgical contra-indication

        Exclusion Criteria:

          -  Mammary carcinoma recurrence

          -  Previous same side mammary reduction

          -  Previous lumpectomy

          -  Contra-indication to surgery

          -  Pregnant or breast feeding patient

          -  Denial of participation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Céline CHAULEUR, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Saint Etienne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Saint-Etienne</name>
      <address>
        <city>Saint-Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2014</study_first_submitted>
  <study_first_submitted_qc>October 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 30, 2014</study_first_posted>
  <results_first_submitted>September 5, 2017</results_first_submitted>
  <results_first_submitted_qc>September 5, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">April 9, 2018</results_first_posted>
  <last_update_submitted>September 5, 2017</last_update_submitted>
  <last_update_submitted_qc>September 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sentinel lymph node</keyword>
  <keyword>indocyanine green</keyword>
  <keyword>fluorescence method</keyword>
  <keyword>radioisotope conventional method</keyword>
  <keyword>breast cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Double Detection Indocyanine + Isotope</title>
          <description>intradermal injection of 2.5 milligrams of indocyanine green and 20 MBq of technetium 99 before breast surgery
indocyanine green: One injection, 2.5 milligrams per patient, intradermal use
isotope: One injection, 20 MBq techntium99, intradermal use</description>
        </group>
        <group group_id="P2">
          <title>Isotope Detection Alone</title>
          <description>intradermal injection of 20 MBq of technetium 99 before breast surgery
isotope: One injection, 20 MBq techntium99, intradermal use</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="49"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Double Detection Indocyanine + Isotope</title>
          <description>intradermal injection of 2.5 milligrams of indocyanine green and 20 MBq of technetium 99 before breast surgery
indocyanine green: One injection, 2.5 milligrams per patient, intradermal use
isotope: One injection, 20 MBq techntium99, intradermal use</description>
        </group>
        <group group_id="B2">
          <title>Isotope Detection Alone</title>
          <description>intradermal injection of 20 MBq of technetium 99 before breast surgery
isotope: One injection, 20 MBq techntium99, intradermal use</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="50"/>
            <count group_id="B2" value="49"/>
            <count group_id="B3" value="99"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="49"/>
                    <count group_id="B3" value="99"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62.2" spread="12.0"/>
                    <measurement group_id="B2" value="60.2" spread="12.5"/>
                    <measurement group_id="B3" value="61.3" spread="12.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="49"/>
                    <count group_id="B3" value="99"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="99"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>height, continuous</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="49"/>
                    <count group_id="B3" value="99"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="161.1" spread="5.4"/>
                    <measurement group_id="B2" value="160.4" spread="6.1"/>
                    <measurement group_id="B3" value="160.8" spread="5.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>weight, continuous</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="49"/>
                    <count group_id="B3" value="99"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69.6" spread="13"/>
                    <measurement group_id="B2" value="65.0" spread="11.1"/>
                    <measurement group_id="B3" value="67.3" spread="12.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>age of first menstruation, continuous</title>
          <population>data not find</population>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="47"/>
                    <count group_id="B2" value="40"/>
                    <count group_id="B3" value="87"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12.8" spread="1.5"/>
                    <measurement group_id="B2" value="12.8" spread="1.4"/>
                    <measurement group_id="B3" value="12.8" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>menopause</title>
          <population>Data not found</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="48"/>
                    <count group_id="B3" value="98"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>tumor size</title>
          <population>data not found</population>
          <units>mm</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="49"/>
                    <count group_id="B2" value="48"/>
                    <count group_id="B3" value="97"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15" lower_limit="10" upper_limit="25"/>
                    <measurement group_id="B2" value="15" lower_limit="11" upper_limit="22.5"/>
                    <measurement group_id="B3" value="15" lower_limit="10" upper_limit="23.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Patients With Less Than Two Lymph Nodes Detected</title>
        <description>Number of patients with less than two lymph nodes detected by indocyanine (ICG) + isotope versus isotope detection alone</description>
        <time_frame>peroperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Double Detection Indocyanine + Isotope</title>
            <description>intradermal injection of 2.5 milligrams of indocyanine green and 20 MBq of technetium 99 before breast surgery
indocyanine green: One injection, 2.5 milligrams per patient, intradermal use
isotope: One injection, 20 MBq techntium99, intradermal use</description>
          </group>
          <group group_id="O2">
            <title>Isotope Detection Alone</title>
            <description>intradermal injection of 20 MBq of technetium 99 before breast surgery
isotope: One injection, 20 MBq techntium99, intradermal use</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With Less Than Two Lymph Nodes Detected</title>
          <description>Number of patients with less than two lymph nodes detected by indocyanine (ICG) + isotope versus isotope detection alone</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Lymph Nodes ICG Positive and Tc Positive</title>
        <description>Number of lymph nodes Indocyanine green (ICG) positive and Tc (Technetium)positive</description>
        <time_frame>Peroperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Double Detection Indocyanine + Isotope</title>
            <description>intradermal injection of 2.5 milligrams of indocyanine green and 20 MBq of technetium 99 before breast surgery
indocyanine green: One injection, 2.5 milligrams per patient, intradermal use
isotope: One injection, 20 MBq techntium99, intradermal use</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Lymph Nodes ICG Positive and Tc Positive</title>
          <description>Number of lymph nodes Indocyanine green (ICG) positive and Tc (Technetium)positive</description>
          <units>lymph nodes</units>
          <param>Number</param>
          <units_analyzed>lymph nodes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>lymph nodes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="108"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Lymph Nodes ICG Positive and Tc Negative</title>
        <description>Number of lymph nodes Indocyanine green (ICG) positive and Tc (Technetium) negative</description>
        <time_frame>Peroperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Double Detection Indocyanine + Isotope</title>
            <description>intradermal injection of 2.5 milligrams of indocyanine green and 20 MBq of technetium 99 before breast surgery
indocyanine green: One injection, 2.5 milligrams per patient, intradermal use
isotope: One injection, 20 MBq techntium99, intradermal use</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Lymph Nodes ICG Positive and Tc Negative</title>
          <description>Number of lymph nodes Indocyanine green (ICG) positive and Tc (Technetium) negative</description>
          <units>lymph nodes</units>
          <param>Number</param>
          <units_analyzed>Lymph nodes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Lymph nodes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="108"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Lymph Nodes ICG Negative and Tc Positive</title>
        <description>Number of lymph nodes Indocyanine green (ICG) negative and Tc (Technetium) positive</description>
        <time_frame>Peroperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Double Detection Indocyanine + Isotope</title>
            <description>intradermal injection of 2.5 milligrams of indocyanine green and 20 MBq of technetium 99 before breast surgery
indocyanine green: One injection, 2.5 milligrams per patient, intradermal use
isotope: One injection, 20 MBq techntium99, intradermal use</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Lymph Nodes ICG Negative and Tc Positive</title>
          <description>Number of lymph nodes Indocyanine green (ICG) negative and Tc (Technetium) positive</description>
          <units>lymph nodes</units>
          <param>Number</param>
          <units_analyzed>lymph nodes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>lymph nodes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="108"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Comparison Between Groups of the Time of the Surgery</title>
        <description>time from incision to wound closure</description>
        <time_frame>Peroperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Double Detection Indocyanine + Isotope</title>
            <description>intradermal injection of 2.5 milligrams of indocyanine green and 20 MBq of technetium 99 before breast surgery
indocyanine green: One injection, 2.5 milligrams per patient, intradermal use
isotope: One injection, 20 MBq techntium99, intradermal use</description>
          </group>
          <group group_id="O2">
            <title>Isotope Detection Alone</title>
            <description>intradermal injection of 20 MBq of technetium 99 before breast surgery
isotope: One injection, 20 MBq techntium99, intradermal use</description>
          </group>
        </group_list>
        <measure>
          <title>Comparison Between Groups of the Time of the Surgery</title>
          <description>time from incision to wound closure</description>
          <units>minuts</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.5" lower_limit="72" upper_limit="122"/>
                    <measurement group_id="O2" value="76" lower_limit="59" upper_limit="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Comparison Between Groups of Anesthesia Time</title>
        <description>time from the injection of anesthesic to the waking</description>
        <time_frame>Peroperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Double Detection Indocyanine + Isotope</title>
            <description>intradermal injection of 2.5 milligrams of indocyanine green and 20 MBq of technetium 99 before breast surgery
indocyanine green: One injection, 2.5 milligrams per patient, intradermal use
isotope: One injection, 20 MBq techntium99, intradermal use</description>
          </group>
          <group group_id="O2">
            <title>Isotope Detection Alone</title>
            <description>intradermal injection of 20 MBq of technetium 99 before breast surgery
isotope: One injection, 20 MBq techntium99, intradermal use</description>
          </group>
        </group_list>
        <measure>
          <title>Comparison Between Groups of Anesthesia Time</title>
          <description>time from the injection of anesthesic to the waking</description>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="171" lower_limit="95" upper_limit="301"/>
                    <measurement group_id="O2" value="152" lower_limit="85" upper_limit="365"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time From Injection of One Dose ICG Injection to Incision Time</title>
        <description>time from injection of one dose ICG injection to incision time</description>
        <time_frame>Peroperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Double Detection Indocyanine + Isotope</title>
            <description>intradermal injection of 2.5 milligrams of indocyanine green and 20 MBq of technetium 99 before breast surgery
indocyanine green: One injection, 2.5 milligrams per patient, intradermal use
isotope: One injection, 20 MBq techntium99, intradermal use</description>
          </group>
        </group_list>
        <measure>
          <title>Time From Injection of One Dose ICG Injection to Incision Time</title>
          <description>time from injection of one dose ICG injection to incision time</description>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.5" lower_limit="13" upper_limit="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Comparison Between Groups of Time Surgery Node</title>
        <description>time from incision time to the last node surgery</description>
        <time_frame>Peroperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Double Detection Indocyanine + Isotope</title>
            <description>intradermal injection of 2.5 milligrams of indocyanine green and 20 MBq of technetium 99 before breast surgery
indocyanine green: One injection, 2.5 milligrams per patient, intradermal use
isotope: One injection, 20 MBq techntium99, intradermal use</description>
          </group>
          <group group_id="O2">
            <title>Isotope Detection Alone</title>
            <description>intradermal injection of 20 MBq of technetium 99 before breast surgery
isotope: One injection, 20 MBq techntium99, intradermal use</description>
          </group>
        </group_list>
        <measure>
          <title>Comparison Between Groups of Time Surgery Node</title>
          <description>time from incision time to the last node surgery</description>
          <units>minuts</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="171" lower_limit="142" upper_limit="200"/>
                    <measurement group_id="O2" value="162.3" lower_limit="125" upper_limit="194"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With ICG Allergy</title>
        <description>allergy is : redness, edema, itching, larynges edema and/or allergic shock</description>
        <time_frame>peroperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Double Detection Indocyanine + Isotope</title>
            <description>intradermal injection of 2.5 milligrams of indocyanine green and 20 MBq of technetium 99 before breast surgery
indocyanine green: One injection, 2.5 milligrams per patient, intradermal use
isotope: One injection, 20 MBq techntium99, intradermal use</description>
          </group>
          <group group_id="O2">
            <title>Isotope Detection Alone</title>
            <description>intradermal injection of 20 MBq of technetium 99 before breast surgery
isotope: One injection, 20 MBq techntium99, intradermal use</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With ICG Allergy</title>
          <description>allergy is : redness, edema, itching, larynges edema and/or allergic shock</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With ICG Allergy</title>
        <description>allergy is : redness, edema, itching, larynges edema and/or allergic shock</description>
        <time_frame>1 hour after the end of the surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Double Detection Indocyanine + Isotope</title>
            <description>intradermal injection of 2.5 milligrams of indocyanine green and 20 MBq of technetium 99 before breast surgery
indocyanine green: One injection, 2.5 milligrams per patient, intradermal use
isotope: One injection, 20 MBq techntium99, intradermal use</description>
          </group>
          <group group_id="O2">
            <title>Isotope Detection Alone</title>
            <description>intradermal injection of 20 MBq of technetium 99 before breast surgery
isotope: One injection, 20 MBq techntium99, intradermal use</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With ICG Allergy</title>
          <description>allergy is : redness, edema, itching, larynges edema and/or allergic shock</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With ICG Allergy</title>
        <description>allergy is : redness, edema, itching, larynges edema and/or allergic shock</description>
        <time_frame>Month 2</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Double Detection Indocyanine + Isotope</title>
            <description>intradermal injection of 2.5 milligrams of indocyanine green and 20 MBq of technetium 99 before breast surgery
indocyanine green: One injection, 2.5 milligrams per patient, intradermal use
isotope: One injection, 20 MBq techntium99, intradermal use</description>
          </group>
          <group group_id="O2">
            <title>Isotope Detection Alone</title>
            <description>intradermal injection of 20 MBq of technetium 99 before breast surgery
isotope: One injection, 20 MBq techntium99, intradermal use</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With ICG Allergy</title>
          <description>allergy is : redness, edema, itching, larynges edema and/or allergic shock</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Double Detection Indocyanine + Isotope</title>
          <description>intradermal injection of 2.5 milligrams of indocyanine green and 20 MBq of technetium 99 before breast surgery
indocyanine green: One injection, 2.5 milligrams per patient, intradermal use
isotope: One injection, 20 MBq techntium99, intradermal use</description>
        </group>
        <group group_id="E2">
          <title>Isotope Detection Alone</title>
          <description>intradermal injection of 20 MBq of technetium 99 before breast surgery
isotope: One injection, 20 MBq techntium99, intradermal use</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (10.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>lymphocele</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="50"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>hematoma</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="50"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Pr Céline CHAULEUR</name_or_title>
      <organization>CHU Saint-Etienne</organization>
      <phone>04 77 82 86 11 ext +33</phone>
      <email>celine.chauleur@chu-st-etienne.fr</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

